Alina Bulatova

Ms. Alina Bulatova


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LZLazzat Zhussupbekova
Lazzat Zhussupbekova
ABAlina Bulatova
Alina Bulatova
Dinara NurkinaDinara Nurkina
Dinara Nurkina
KKKlara Kurmangaliyeva
Klara Kurmangaliyeva
VRVenera Rakhmetova
Venera Rakhmetova
EAElmira Akhmedyarova
Elmira Akhmedyarova
Over the past decade, the growth of Helicobacter pylori antibiotic resistance has had an increasingly significant impact on the choice of eradication therapy regimens, significantly limiting the number of effective treatment options. The Maastricht VI guidelines consider the use of probiotics as one way to optimise therapy and increase the likelihood of successful eradication. In this regard, the study of the possible mechanisms of action of probiotic preparations on antibiotic-resistant strains of H. pylori, as well as their possible role in preventing the development of resistance, is of considerable interest and may contribute to improving the quality of eradication therapy in the near future. The aim of the study is to determine the role of probiotics in modifying the microbiota during and after eradication therapy, as well as to assess their potential impact on the development of antibiotic resistance. A search for scientific publications was conducted in international and national bibliographic databases: PubMed, Embase, Scopus, Web of Science Core Collection, Google Scholar, and eLIBRARY.ru. The search was conducted in English, Russian, and Kazakh for the period from 26 April 2015 to 14 July 2025. The review includes 41 publications. Eradication therapy has a pronounced negative effect on the intestinal microbiota, leading to disruption of its composition and the development of side effects that reduce treatment tolerability. A number of studies in recent years have demonstrated a link between antibiotic therapy and the development of antibiotic resistance caused by genetic rearrangements and mutations in the gut microbiota genome. As an additional approach to correcting these adverse effects, special attention is paid to the use of probiotics. According to the research results, probiotic preparations help reduce the frequency of side effects of eradication therapy and may increase its effectiveness against antibiotic-resistant strains of H. pylori. The use of probiotic preparations in the treatment of resistant strains of Helicobacter pylori is a promising direction that opens up new opportunities for optimising eradication regimens. However, this approach requires further clinical and experimental studies to confirm its effectiveness and form reasonable prognostic conclusions.

4 November 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LZLazzat Zhussupbekova
Lazzat Zhussupbekova
YOYelvira Omralina
Yelvira Omralina
Aigyul IzhanovaAigyul Izhanova
Aigyul Izhanova
ABAlina Bulatova
Alina Bulatova
VRVenera Rakhmetova
Venera Rakhmetova
Kassymzhomart ZholamanovKassymzhomart Zholamanov
Kassymzhomart Zholamanov
The issue of early cancer diagnosis today is characterized by late symptom manifestation, difficulties in timely performing diagnostic procedures, and a lack of biomarkers that fully meet the criteria for sensitivity and specificity. An expanded search for novel diagnostic methods currently shows promise regarding the use of altered protein glycosylation patterns. This assumption is grounded in the ability of post-translational modifications, including changes in glycoprotein profiles and glycan structures, to serve as a signal of alterations at the level of synthetic processes. Tumor-associated glycan structures are released into the bloodstream, creating an opportunity for their detection using minimally invasive diagnostic methods. This article summarizes current data on the use of glycan signatures as cancer biomarkers for gastrointestinal and hepatopancreatic systems. The study utilized methodological discoveries in the fields of glycoproteomics and glycomics as informational material, actively integrating modern branches of omics technologies. Mass spectrometry and analytical methods made it possible to identify the most informative glycoproteomic and glycan biomarkers, the diagnostic efficacy of which was evaluated on internal and external validation cohorts. Analysis of the obtained data was performed with consideration of the limitations of the included studies, including small sample sizes, cohort heterogeneity, and potential publication bias. To enhance informativeness by developing new validation panels for early cancer detection, research recommendations for conducting new prospective studies are provided at the end of the review.